Which Patients Might Benefit from Postmastectomy Radiotherapy in Breast Cancer Patients with T1-2 Tumor and 1-3 Axillary Lymph Nodes Metastasis?
Moonkyoo Kong, Seong Eon Hong
Cancer Res Treat. 2013;45(2):103-111. Published online 2013 Jun 30 DOI: https://doi.org/10.4143/crt.2013.45.2.103
Citations to this article as recorded by 
A Prognostic Risk Stratification Model to Identify Potential Population Benefiting From Postmastectomy Radiotherapy in T1–2 Breast Cancer With 1–3 Positive Axillary Lymph Nodes
Niuniu Hou, Juliang Zhang, Lu Yang, Ying Wu, Zhe Wang, Mingkun Zhang, Li Yang, Guangdong Hou, Jianfeng Wu, Yidi Wang, Bingyao Dong, Lili Guo, Mei Shi, Rui Ling
Frontiers in Oncology.2021;[Epub] CrossRef
SKIN AND SUBCUTANEOUS ADIPOSE TISSUE DAMAGE AFTER RADIATION THERAPY IN BREAST CANCER PATIENTS
D. Bazyka, O. Litvinenko, S. Bugaytsov, G. Shakhrai
Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology.2021; 26: 18. CrossRef
Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series
Samantha Grossmith, Anvy Nguyen, Jiani Hu, Jennifer K. Plichta, Faina Nakhlis, Linda Cutone, Laura Dominici, Mehra Golshan, Margaret Duggan, Katharine Carter, Esther Rhei, Thanh Barbie, Katherina Calvillo, Suniti Nimbkar, Jennifer Bellon, Julia Wong, Rina
Annals of Surgical Oncology.2018; 25(12): 3527. CrossRef
A prognostic score model to determine which breast cancer patients with 1-3 positive lymph nodes after modified radical mastectomy should receive radiotherapy
Dawei Chen, Haiyong Wang, Xinyu Song, Fang Shi, Li Kong, Jinming Yu
Oncotarget.2018; 9(1): 385. CrossRef
Postmastectomy radiation therapy for breast cancer patients with one to three positive lymph nodes: a propensity score matching analysis
Jiamao Lin, Cheng Li, Chenyue Zhang, Fang Shi, Haiyong Wang
Future Oncology.2017; 13(16): 1395. CrossRef
Predicting loco-regional recurrence risk in T1, T2 breast cancer with 1–3 positive axillary nodes postmastectomy: Development of a predictive nomogram
T Wadasadawala, S Kannan, S Gudi, A Rishi, A Budrukkar, V Parmar, T Shet, S Desai, S Gupta, R Badwe, R Sarin
Indian Journal of Cancer.2017; 54(1): 352. CrossRef
Comparison of Treatment Outcomes between Breast Conserving Surgery Followed by Radiotherapy and Mastectomy Alone in Patients with T1-2 Stage and 1-3 Axillary Lymph Nodes in the Era of Modern Adjuvant Systemic Treatments
Sang-Won Kim, Mison Chun, Sehwan Han, Yong Sik Jung, Jin Hyuk Choi, Seok Yun Kang, Hyunsoo Jang, Sunmi Jo, William B. Coleman
PLOS ONE.2016; 11(9): e0163748. CrossRef
Improvement of survival with postmastectomy radiotherapy in patients with 1-3 positive axillary lymph nodes: A systematic review and meta-analysis of the current literature
Hannah Headon, Abdul Kasem, Reham Almukbel, Kefah Mokbel
Molecular and Clinical Oncology.2016; 5(4): 429. CrossRef
ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy
Hee‐Jun Kim, Seock‐Ah Im, Bhumsuk Keam, Hye Seon Ham, Kyung Hun Lee, Tae Yong Kim, Yu Jung Kim, Do‐Youn Oh, Jee Hyun Kim, Wonshik Han, In‐Jin Jang, Tae‐You Kim, In Ae Park, Dong Young Noh
Cancer Science.2015; 106(1): 86. CrossRef
Conservative Axillary Surgery in Breast Cancer Patients Undergoing Mastectomy: Long-Term Results
Michael S. Cowher, Stephen R. Grobmyer, Joanne Lyons, Colin O'Rourke, Deborah Baynes, Joseph P. Crowe
Journal of the American College of Surgeons.2014; 218(4): 819. CrossRef